US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

First Trust Dorsey Wright Dynamic Focus 5 ETF

34.58

+0.01500.04%

Post-market: 34.50-0.0800-0.23%16:05 EDT

Volume:23.61K

Turnover:816.14K

Market Cap:129.68M

PE:- -

High:34.59

Open:34.59

Low:34.50

Close:34.57

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/FVC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","market":"US","secType":"STK","nameCN":"First Trust Dorsey Wright Dynamic Focus 5 ETF","latestPrice":34.58,"timestamp":1745611200000,"preClose":34.565,"halted":0,"volume":23605,"hourTrading":{"tag":"盘后","latestPrice":34.5,"preClose":34.58,"latestTime":"16:05 EDT","volume":2,"amount":69.16,"timestamp":1745611511340},"delay":0,"floatShares":3750002,"shares":3750002,"eps":0,"marketStatus":"Not Yet Opened","change":0.015,"latestTime":"04-25 16:00:00 EDT","open":34.59,"high":34.59,"low":34.5,"amount":816143.7964,"amplitude":0.002604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":34.565,"sharesOutstanding":3750002,"nav":34.57,"aum":129637569.14,"bidAskSpread":0.002997,"postHourTrading":{"tag":"盘后","latestPrice":34.5,"preClose":34.58,"latestTime":"16:05 EDT","volume":2,"amount":69.16,"timestamp":1745611511340},"volumeRatio":1.1628422423295883},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FVC\",,,,,undefined,":{"symbol":"FVC","floatShares":3750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1628422423295883,"shares":3750002,"dividePrice":0.2639,"high":34.59,"amplitude":0.002604,"preClose":34.565,"low":34.5,"week52Low":30.39,"pbRate":"--","week52High":39.21,"institutionHeld":0,"latestPrice":34.58,"eps":0,"divideRate":0.007632,"volume":23605,"delay":0,"ttmEps":0,"open":34.59,"prevYearClose":36.55,"prevWeekClose":34.11,"prevMonthClose":35.18,"prevQuarterClose":35.18,"fiveDayClose":34.11,"twentyDayClose":35.58,"sixtyDayClose":37.42},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FVC\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FVC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516533666","title":"Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2516533666","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516533666?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:05","pubTimestamp":1741035900,"startTime":"0","endTime":"0","summary":"Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO, Calif., March  03, 2025  (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clini","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3036046/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FVC","LENZ","BK4139","CTA"],"gpt_icon":0},{"id":"2516225631","title":"Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2516225631","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516225631?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:27","pubTimestamp":1741012020,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., March  03, 2025  (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendation by the trial’s i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/03/3035743/0/en/Pliant-Therapeutics-Provides-Update-on-BEACON-IPF-a-Phase-2b-3-Trial-in-Patients-with-Idiopathic-Pulmonary-Fibrosis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","FVC"],"gpt_icon":0},{"id":"2508645864","title":"United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2508645864","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508645864?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:00","pubTimestamp":1738670400,"startTime":"0","endTime":"0","summary":"Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progression. SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., February 04, 2025----United Therapeutics Corporation , a public benefit corporation, announced full enrollment of the TETON 1 study evaluating the use of Tyvaso  inhalation solution  for the treatment of idiopathic pulmonary fibrosis .Further, open label extension data published in 2023 showed these improvements in FVC were sustained for at least 64 weeks. For those patients who received placebo during the INCREASE study, marked improvements in FVC were observed following transition to nebulized Tyvaso during the open-label extension study. These data points, combined with substantial preclinical evidence of antifibrotic activity of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-therapeutics-corporation-announces-full-120000413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FVC","BK4593","UTHR","LU1699723380.USD","BK4532","PBC","BK4139","LU1571399168.USD","QID"],"gpt_icon":0},{"id":"2508811403","title":"Amicus Therapeutics Announces Presentations and Posters at the 21st Annual WORLDSymposium™ 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508811403","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508811403?lang=en_us&edition=fundamental","pubTime":"2025-02-03 20:00","pubTimestamp":1738584000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., Feb. 03, 2025  -- Amicus Therapeutics , today announced that two oral presentations and 20 posters across its development programs will be included at the 21st Annual WORLDSymposium 2025, being held February 3-7, 2025 in San Diego, CA.“As part of our ongoing efforts to advance our scientific leadership in Fabry and Pompe diseases, Amicus researchers will present two oral presentations and 20 posters at this year’s WORLDSymposium,” said Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc. “We’re proud of the progress we are making for patients living with Fabry and Pompe and are committed to build on this momentum in pursuit of our mission to develop and deliver transformative medicines for people living with rare diseases.”Abstract Title:Miglustat: A first-in-class enzyme stabilizer for late-onset Pompe disease. Presenter: Robert J. Hopkin, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, U.S.A.Abstract Title: Clinically im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-therapeutics-announces-presentations-posters-120000026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","LU2065170008.USD","FOLD","LU2065171402.SGD","BK4139","FVC","LU2065169927.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FVC\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"FVC","amount":0.1174,"announcedDate":"2025-03-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-27","defaultRemindTime":1743082200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-27","currency":"USD","dateTimestamp":1743048000000,"payDate":"2025-03-31"},{"date":"2024-12-13","symbol":"FVC","amount":0.0275,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"},{"date":"2024-09-26","symbol":"FVC","amount":0.0524,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-26","defaultRemindTime":1727357400000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-30","payableDate":"2024-09-26","currency":"USD","dateTimestamp":1727323200000,"payDate":"2024-09-30"},{"date":"2024-06-27","symbol":"FVC","amount":0.0666,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-27","defaultRemindTime":1719495000000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-27","currency":"USD","dateTimestamp":1719460800000,"payDate":"2024-06-28"},{"date":"2024-03-21","symbol":"FVC","amount":0.139,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-22","defaultRemindTime":1711027800000,"name":"First Trust Dorsey Wright Dynamic Focus 5 ETF","recordDate":"2024-03-28","payableDate":"2024-03-22","currency":"USD","dateTimestamp":1710993600000,"payDate":"2024-03-28"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FVC\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.0365,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0068,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.1017,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0169,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.0459,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FVC\",market:\"US\",delay:false,,,undefined,":{}}}